Tumor Necrosis Factor Inhibitor Injection from Germany
Biotech TNF-alpha inhibitor like infliximab for therapeutic treatment of rheumatoid arthritis and Crohn's disease. Classified under HTS 3002.90.52 as modified immunological products regulating immune processes. Administered via infusion for chronic inflammation.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Black box warning documentation may expedite review
• Ensure monoclonal specificity testing for classification
• Volume limits for personal import under traveler exemptions